Counterweight Ventures’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
21,134
+432
| +2% | +$20K | 0.64% | 43 |
|
|
2025
Q1 | $1.26M | Buy |
20,702
+499
| +2% | +$30.4K | 0.9% | 42 |
|
|
2024
Q4 | $1.14M | Sell |
20,203
-29
| -0.1% | -$1.64K | 0.81% | 42 |
|
|
2024
Q3 | $1.05M | Sell |
20,232
-5,841
| -22% | -$302K | 0.74% | 43 |
|
|
2024
Q2 | $1.08M | Buy |
26,073
+1,971
| +8% | +$81.9K | 0.82% | 38 |
|
|
2024
Q1 | $1.31M | Buy |
24,102
+9,331
| +63% | +$506K | 1.05% | 38 |
|
|
2023
Q4 | $758K | Buy |
+14,771
| New | +$758K | 0.69% | 42 |
|